Mini-Device implanted in tumors could reveal which drug works best
Knowledge-focused
By invitation only
This early-phase study tests a tiny implantable device that delivers very small amounts of several approved cancer drugs directly into skin cancer tumors. The goal is to see if the device can safely and effectively identify which drug triggers the most cancer cell death in that s…
Early phase 1 • Sponsor: Oliver Jonas • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:34 UTC